Provided by Tiger Trade Technology Pte. Ltd.

Nextcure Inc.

4.24
+0.06001.44%
Post-market: 4.21-0.0300-0.71%19:55 EDT
Volume:282.28K
Turnover:1.18M
Market Cap:17.25M
PE:-0.28
High:4.53
Open:4.20
Low:4.01
Close:4.18
52wk High:15.74
52wk Low:1.55
Shares:4.07M
Float Shares:2.62M
Volume Ratio:0.45
T/O Rate:10.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.3195
EPS(LYR):-19.6464
ROE:-132.40%
ROA:-66.71%
PB:0.65
PE(LYR):-0.22

Loading ...

NextCure trading resumes

TIPRANKS
·
Jul 16

NASDAQ Trade Halt Volatility Trading Pause at 10:36 Am

Reuters
·
Jul 16

Top Premarket Decliners

MT Newswires Live
·
Jul 15

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live
·
Jul 14

U.S. Stocks on the Move-lulu's Fashion Lounge Holdings, Wells Fargo, Bank of America

Reuters
·
Jul 14

Top Premarket Gainers

MT Newswires Live
·
Jul 14

Nextcure Jumps on Merger with Avere, $320 Million Financing

Reuters
·
Jul 14

Hansoh Pharma Licenses Oral IL-23 Drug Hs-20118 to Avere in Deal Worth up to USD 2.3 Billion

Reuters
·
Jul 14

Nextcure Agrees to Merge with Avere Therapeutics in All-stock Deal

Reuters
·
Jul 14

Hansoh Pharmaceutical - Avere Therapeutics to Merge into Nextcure Under Merger Agreement Signed July 14, 2026

THOMSON REUTERS
·
Jul 14

Nextcure - Announces Concurrent $320 Mln Private Placement Led by Fairmount and Hansoh

THOMSON REUTERS
·
Jul 14

Nextcure Inc: Combined Company Plans to Operate Under Name Avere Therapeutics

THOMSON REUTERS
·
Jul 14

Nextcure - Andrew Cheng to Serve as CEO, President, and Chairman of Combined Company

THOMSON REUTERS
·
Jul 14

Nextcure - Combined Company to Operate as Avere Therapeutics, Trade as Avrx After Merger in H2 2026

THOMSON REUTERS
·
Jul 14

Nextcure - Stockholders to Own 1.21%, Avere Stockholders 98.79% of Combined Company at Closing

THOMSON REUTERS
·
Jul 14

Nextcure and Avere Therapeutics Announce Merger to Advance Once-weekly Oral Il-23 Therapy

THOMSON REUTERS
·
Jul 14

Nextcure - Stockholders to Receive CVR for 90% of Net Proceeds from Pipeline Monetization for Two Years Post-closing

THOMSON REUTERS
·
Jul 14

Nextcure - Avere to Pay Hansoh $120 Mln Upfront, up to $2.18 Bln in Milestones, Plus Royalties for Avr-1 Ex-china Rights

THOMSON REUTERS
·
Jul 14

Press Release: Nextcure and Avere Therapeutics Announce Merger to Advance Once-weekly Oral IL-23 Therapy

Dow Jones
·
Jul 14

Nextcure Shareholders Approve Amended 2019 Incentive Plan Adding 80,000 Shares

Reuters
·
Jun 25